Predictors of target lesion failure after percutaneous coronary intervention with a drug-coated balloon for de novo lesions

被引:6
|
作者
Lee, Tetsumin [1 ]
Ashikaga, Takashi [1 ]
Nozato, Toshihiro [1 ]
Nagata, Yasutoshi [1 ]
Kaneko, Masakazu [1 ]
Miyazaki, Ryoichi [1 ]
Misawa, Toru [1 ]
Taomoto, Yuta [1 ]
Okata, Shinichiro [1 ]
Nagase, Masashi [1 ]
Horie, Tomoki [1 ]
Terui, Mao [1 ]
Kachi, Daigo [1 ]
Odanaka, Yuki [1 ]
Matsuda, Kazuki [1 ]
Naito, Michihito [1 ]
Koido, Ayaka [1 ]
Yonetsu, Taishi [2 ]
Sasano, Tetsuo [2 ]
机构
[1] Japanese Red Cross Musashino Hosp, Dept Cardiol, 1-26-1 Kyonancho, Tokyo 1808610, Japan
[2] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan
关键词
calcified stenosis; drug-eluting balloon; optical coherence tomography; SIROLIMUS-ELUTING STENT; OUTCOMES; HEMODIALYSIS; DISSECTIONS; VESSELS; IMPACT;
D O I
10.4244/EIJ-D-23-01006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: There are limited data about determinant factors of target lesion failure (TLF) in lesions after percutaneous coronary intervention (PCI) using a drug-coated balloon (DCB) for de novo coronary artery lesions, including optical coherence tomography (OCT) findings. AIMS: The present study aims to investigate the associated factors of TLF in de novo coronary artery lesions with DCB treatment. METHODS: We retrospectively enrolled 328 de novo coronary artery lesions in 328 patients who had undergone PCI with a DCB. All lesions had been treated without a stent, and both pre- and post-PCI OCT had been carried out. Patients were divided into two groups, with or without TLF, which was defined as a composite of culprit lesionrelated cardiac death, myocardial infarction, and target lesion revascularisation, and the associated factors of TLF were assessed. RESULTS: At the median follow-up period of 460 days, TLF events occurred in 31 patients (9.5%) and were associated with patients requiring haemodialysis (HD; 29.0% vs 10.8%), with a severely calcified lesion (median maximum calcium arc 215 degrees vs 104 degrees), and with the absence of OCT medial dissection (16.1% vs 60.9%) as opposed to those without TLF events. In Cox multivariable logistic regression analysis, HD (hazard ratio [HR]: 2.26, 95% confidence interval [CI]: 1.00-5.11; p=0.049), maximum calcium arc (per 90 degrees, HR: 1.34, 95% CI: 1.05-1.72; p=0.02), and the absence of post-PCI medial dissection on OCT (HR: 8.24, 95% CI: 3.15-21.6; p<0.001) were independently associated with TLF. CONCLUSIONS: In de novo coronary artery lesions that received DCB treatment, factors associated with TLF were being on HD, the presence of a severely calcified lesion, and the absence of post-PCI medial dissection.
引用
收藏
页码:e818 / e825
页数:9
相关论文
共 50 条
  • [41] Short-term outcomes from drug-coated balloon for coronary de novo lesions in large vessels
    Lu, Wenjie
    Zhu, Yongjian
    Han, Zhanying
    Sun, Guoju
    Qin, Xiaofei
    Wang, Zhengbin
    Liu, Guanghui
    Wang, Xi
    Wang, Xule
    Pan, Liang
    Qiu, Chunguang
    JOURNAL OF CARDIOLOGY, 2019, 73 (1-2) : 151 - 155
  • [42] Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery
    Gitto, Mauro
    Sticchi, Alessandro
    Chiarito, Mauro
    Novelli, Laura
    Leone, Pier Pasquale
    Mincione, Gianluca
    Oliva, Angelo
    Condello, Francesco
    Rossi, Marco Luciano
    Regazzoli, Damiano
    Gasparini, Gabriele
    Cozzi, Ottavia
    Stefanini, Giulio G.
    Condorelli, Gianluigi
    Reimers, Bernhard
    Mangieri, Antonio
    Colombo, Antonio
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (12) : E013232
  • [43] Upfront scoring balloon predilatation in treatment of de-novo lesions with drug-coated balloon angioplasty
    Rajagopal, Rajinikanth
    MINERVA CARDIOLOGY AND ANGIOLOGY, 2024, 72 (03) : 305 - 306
  • [44] Impact of Optimal Preparation Before Drug-Coated Balloon Dilatation for De Novo Lesion in Patients With Coronary Artery Disease
    Konishi, Hirokazu
    Habara, Maoto
    Nasu, Kenya
    Koshida, Ryoji
    Kinoshita, Yoshihisa
    Tsuchikane, Etsuo
    Terashima, Mitsuyasu
    Matsubara, Tetsuo
    Suzuki, Takahiko
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 35 : 91 - 95
  • [45] The Efficacy of Drug-Coated Balloon Angioplasty for De Novo Small Coronary Artery Disease
    Suzuki, Yoriyasu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B268 - B268
  • [46] Risk of Mortality with Paclitaxel Drug-Coated Balloon in De Novo Coronary Artery Disease
    Yerasi, Charan
    Case, Brian C.
    Forrestal, Brian J.
    Kolm, Paul
    Dan, Kazuhiro
    Torguson, Rebecca
    Weintraub, William S.
    Garcia-Garcia, Hector M.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2020, 21 (04) : 549 - 555
  • [47] Two-year outcomes of drug-coated balloon only strategy for de novo lesions in large coronary vessels
    Bando, R.
    Wakatsuki, T.
    Yamaguchi, K.
    Kawabata, Y.
    Takahashi, T.
    Saijo, Y.
    Kadota, M.
    Matsuura, T.
    Ise, T.
    Kusunose, K.
    Yagi, S.
    Yamada, H.
    Soeki, T.
    Akaike, M.
    Sata, M.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [48] Outcomes after drug-coated balloon treatment for patients with calcified coronary lesions
    Ito, Ryuta
    Ueno, Katsumi
    Yoshida, Tamami
    Takahashi, Hiroshi
    Tatsumi, Tomohiko
    Hashimoto, Yasumasa
    Kojima, Yoshinobu
    Kitamura, Tomoya
    Morita, Norihiko
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2018, 31 (04) : 436 - 441
  • [49] Predictors of recurrent restenosis after repeat drug-coated balloon therapy for drug-coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study
    Yanagiuchi, Takashi
    Fukai, Kuniyoshi
    Sogabe, Koji
    Iwasaki, Yoshihiro
    Hirano, Keita
    Kato, Taku
    Yokoi, Hirokazu
    Zen, Kan
    Matoba, Satoaki
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2024, 104 (06) : 1241 - 1250
  • [50] Effect of High-Dose Drug-Coated Balloon Repetition After Drug-Coated Balloon Failure
    Tomoi, Yusuke
    Takahara, Mitsuyoshi
    Soga, Yoshimitsu
    Hirano, Taichi
    Tsunoda, Kazuki
    Katsuki, Tomonori
    Ando, Kenji
    JOURNAL OF ENDOVASCULAR THERAPY, 2023,